Related Experiment Videos

The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity

M Bergman1, T Mustelin, C Oetken

  • 1Department of Pathology, University of Helsinki, Finland.

The EMBO Journal
|August 1, 1992
PubMed

Insights

A newly identified protein tyrosine kinase, p50csk, phosphorylates and suppresses the activity of T cell protein tyrosine kinase p56lck. This discovery reveals a key mechanism in regulating cell signaling and preventing malignant transformation.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Protein tyrosine kinases (PTKs) are crucial for cell signaling, regulating proliferation and differentiation.
  • Dysregulated PTK activity is linked to malignant transformation.
  • The T cell protein tyrosine kinase, p56lck, is normally inhibited by phosphorylation at Tyr-505.

Purpose of the Study:

  • To characterize a human cytosolic PTK, p50csk.
  • To investigate the role of p50csk in regulating p56lck activity.

Main Methods:

  • Biochemical characterization of p50csk.
  • In vitro phosphorylation assays using p56lck and synthetic peptides.

Main Results:

  • p50csk specifically phosphorylates Tyr-505 of p56lck.
  • Phosphorylation of Tyr-505 by p50csk suppressed the catalytic activity of p56lck.
  • p50csk also phosphorylated a synthetic peptide mimicking the Tyr-505 site.

Conclusions:

  • p50csk acts as a negative regulator of p56lck.
  • p50csk may also regulate other Src family kinases.
  • This finding provides insight into the control of T cell signaling pathways.

Related Concept Videos